Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Omer, Dizdar"'
Autor:
Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, Ece Karaca, Yunus Kaygusuz, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 4, Pp 170-176 (2023)
Introduction: Although immune checkpoint inhibitors (ICIs) are widely used in cancer treatment, identifying factors that predict treatment response remains a challenge in clinical practice. There is a need for biomarkers to identify patients who may
Externí odkaz:
https://doaj.org/article/67323cc7fe9e425d97196951b9a3b644
Autor:
Emine Duran, Zeynep Ozge Ozturk, Emre Bilgin, Yahya Büyükaşık, Omer Dizdar, Gozde Kubra Yardimci, Bayram Farisogullari, Zehra Özsoy, Gizem Ayan, Gullu Sandal Uzun, Mustafa Ekici, Erdinc Unaldi, Levent Kilic, Ali Akdoğan, Omer Karadag, Şule Apraş Bilgen, Sedat Kiraz, Umut Kalyoncu, Ali Ihsan Ertenli
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 969-981 (2023)
Abstract Introduction This study aimed to assess the incidence of hematologic malignancy (HM) among inflammatory arthritis (IA) patients receiving tumor necrosis factor inhibitors (TNFi) compared with the general Turkish population. Methods HUR-BIO (
Externí odkaz:
https://doaj.org/article/d6be86e826924b9c80491bed6fee8c46
Autor:
Ozge Saatci, Aysegul Kaymak, Umar Raza, Pelin G. Ersan, Ozge Akbulut, Carolyn E. Banister, Vitali Sikirzhytski, Unal Metin Tokat, Gamze Aykut, Suhail A. Ansari, Hayriye Tatli Dogan, Mehmet Dogan, Pouria Jandaghi, Aynur Isik, Fatma Gundogdu, Kemal Kosemehmetoglu, Omer Dizdar, Sercan Aksoy, Aytekin Akyol, Aysegul Uner, Phillip J. Buckhaults, Yasser Riazalhosseini, Ozgur Sahin
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
The development of chemoresistance is a major hurdle in triple negative breast cancer (TNBC). Here, the authors show that lysyl oxidase (LOX) is overexpressed in chemoresistant TNBCs, and when inhibited reduces collagen cross-linking, fibronectin fib
Externí odkaz:
https://doaj.org/article/f292a5a9fd8f4954a8c5c7cfe015c25d
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 2, Pp 45-48 (2019)
Aim: Recently, three randomized controlled trials evaluated the addition of docetaxel to ADT in advanced hormone-sensitive prostate cancer (aHSPC). Interestingly, all trials showed a trend towards improved OS in the subgroup of patients with Gleason
Externí odkaz:
https://doaj.org/article/38b91bdbfa5842a3918ad42b195e3c97
Autor:
Deniz Can Guven, Hasan Cagri Yildirim, Fatih Kus, Enes Erul, Neyran Kertmen, Omer Dizdar, Sercan Aksoy
Publikováno v:
Expert Review of Anticancer Therapy. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e9b751501d525662c19060b1fbcc656
https://doi.org/10.1080/14737140.2023.2218090
https://doi.org/10.1080/14737140.2023.2218090
Autor:
Deniz Can Guven, Hasan Cagri Yildirim, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktas, Suayib Yalcin, Omer Dizdar
Publikováno v:
Expert Review of Anticancer Therapy. 23:243-256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e593a57d28a53b432f8f1f51eab9f515
https://doi.org/10.1080/14737140.2023.2183844
https://doi.org/10.1080/14737140.2023.2183844
Autor:
Deniz Can Guven, Deniz Aral Ozbek, Taha Koray Sahin, Gozde Kavgaci, Melek Seren Aksun, Enes Erul, Hasan Cagri Yildirim, Elvin Chalabiyev, Cebrayil Cebroyilov, Tolga Yildirim, Omer Dizdar, Sercan Aksoy, Suayib Yalcin, Saadettin Kilickap, Mustafa Erman, Mustafa Arici
Publikováno v:
Anti-Cancer Drugs. 34:783-790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81b81d900815a5a654457235dfca5f5a
https://doi.org/10.1097/cad.0000000000001463
https://doi.org/10.1097/cad.0000000000001463
Autor:
Deniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, Enes Erul, Elvin Chalabiyev, Burak Yasin Aktas, Deniz Yuce, Zafer Arik, Saadettin Kilickap, Sercan Aksoy, Mustafa Erman, Kadir Mutlu Hayran, Serhat Unal, Alpaslan Alp, Omer Dizdar
Publikováno v:
International Journal of Cancer. 152:679-685
We aimed to evaluate the seroconversion rates after two doses of inactive COVID-19 vaccine (CoronaVac) and the benefit of a third dose mRNA vaccine booster in patients with cancer receiving active treatment. Patients with solid tumors receiving activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7812c8d1de80abc934a6536ed35a1fdd
https://doi.org/10.1002/ijc.34280
https://doi.org/10.1002/ijc.34280
Autor:
Elvin Chalabiyev, Safa can Efil, Deniz Can Guven, Hasan Cagri Yildirim, Arif Akyildiz, Fatih Kus, Rashad Ismayilov, Omer Dizdar, Suayib Yalcin, Omer Denizhan Tatar
Background The prognostic nutritional index (PNI), estimated using serum albumin concentration and peripheral blood cell count, is a promising predictor of outcomes in patients with colon cancer. We aimed to show the difference in survival times base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4119f45c74e797388e13f018673551d8
https://doi.org/10.21203/rs.3.rs-2786751/v1
https://doi.org/10.21203/rs.3.rs-2786751/v1
Publikováno v:
Irish Journal of Medical Science (1971 -).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b7a52ae1f57989f5f24009a87f20c42
https://doi.org/10.1007/s11845-023-03297-7
https://doi.org/10.1007/s11845-023-03297-7